Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 489

    1.

    Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.

    Jong MC, Voshol PJ, Muurling M, Dahlmans VE, Romijn JA, Pijl H, Havekes LM.

    Diabetes. 2001 Dec;50(12):2779-85.PMID: 11723061 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.

    Koopmans SJ, Jong MC, Que I, Dahlmans VE, Pijl H, Radder JK, Frölich M, Havekes LM.

    Diabetologia. 2001 Apr;44(4):437-43.PMID: 11357474 [PubMed - indexed for MEDLINE]Related articles

    3.

    Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance.

    Muurling M, van den Hoek AM, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ.

    J Lipid Res. 2004 Jan;45(1):9-16. Epub 2003 Oct 1.PMID: 14523051 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.

    Duivenvoorden I, Teusink B, Rensen PC, Romijn JA, Havekes LM, Voshol PJ.

    Diabetes. 2005 Mar;54(3):664-71.PMID: 15734841 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Protection from obesity in mice lacking the VLDL receptor.

    Goudriaan JR, Tacken PJ, Dahlmans VE, Gijbels MJ, van Dijk KW, Havekes LM, Jong MC.

    Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1488-93.PMID: 11557677 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

    Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.

    Diabetes. 2006 Aug;55(8):2159-70.PMID: 16873678 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance.

    Franckhauser S, Muñoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B, Bosch F.

    Diabetes. 2002 Mar;51(3):624-30.PMID: 11872659 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

    Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS.

    Endocrinology. 2000 Sep;141(9):3388-96.PMID: 10965911 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.

    Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H.

    Diabetes. 1988 Nov;37(11):1549-58.PMID: 3053303 [PubMed - indexed for MEDLINE]Related articles

    11.

    The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.

    Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B.

    J Biol Chem. 2006 Apr 21;281(16):11039-49. Epub 2006 Jan 30.PMID: 16446356 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.

    Jong MC, Dahlmans VE, van Gorp PJ, Breuer ML, Mol MJ, van der Zee A, Frants RR, Hofker MH, Havekes LM.

    Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):934-40.PMID: 8696956 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue.

    Chen N, Liu L, Zhang Y, Ginsberg HN, Yu YH.

    Diabetes. 2005 Dec;54(12):3379-86.PMID: 16306352 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.

    Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T.

    J Biol Chem. 2006 Mar 31;281(13):8748-55. Epub 2006 Jan 23.PMID: 16431926 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice.

    Muurling M, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ.

    Metabolism. 2003 Aug;52(8):1078-83.PMID: 12898477 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.

    Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M.

    Endocrinology. 2006 Sep;147(9):4517-24. Epub 2006 Jun 1.PMID: 16740970 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.

    Moller DE, Chang PY, Yaspelkis BB 3rd, Flier JS, Wallberg-Henriksson H, Ivy JL.

    Endocrinology. 1996 Jun;137(6):2397-405.PMID: 8641192 [PubMed - indexed for MEDLINE]Related articles

    18.

    Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.

    Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, Havekes LM, Romijn JA, Groot PH, Reijngoud DJ, Kuipers F.

    Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E829-38. Epub 2005 Jun 7.PMID: 15941783 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

    Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, Juhan-Vague I.

    Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1150-4.PMID: 10764686 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.

    Jong MC, Gijbels MJ, Dahlmans VE, Gorp PJ, Koopman SJ, Ponec M, Hofker MH, Havekes LM.

    J Clin Invest. 1998 Jan 1;101(1):145-52.PMID: 9421476 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data